Literature DB >> 12060587

Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries.

Jackleen S Marji1, Mong-Heng Wang, Michal Laniado-Schwartzman.   

Abstract

20-Hydroxyeicosatetraenoic acid (20-HETE), a potent vasoconstrictor and mediator of the myogenic response, is a major arachidonic acid metabolite in the microvasculature of the rat kidney formed primarily by the cytochrome P-450 (CYP) 4A isoforms, CYP4A1, CYP4A2, and CYP4A3. We examined CYP4A isoform expression and 20-HETE synthesis in microdissected interlobar, arcuate, and interlobular arteries; mRNA for all CYP4A isoforms was identified by RT-PCR. Western blot analysis indicated that the levels of CYP4A2/4A3-immunoreactive protein increased with decreased arterial diameter, whereas those of CYP4A1-immunoreactive protein remained unchanged. 20-HETE synthesis was the highest in the interlobular arteries (17 +/- 1.62 nmol. mg(-1). h(-1)) and, like CYP4A2/4A3-immunoreactive protein, decreased with increasing vessel diameter (4.5 +/- 1.21, 2.65 +/- 0.58, and 0.81 +/- 0.14 nmol. mg(-1). h(-1) in the arcuate, interlobar, and segmental arteries, respectively). 20-HETE synthesis in the renal artery and the abdominal aorta was undetectable. The observed decreased immunoreactivity of NADPH-cytochrome P-450 (c) oxidoreductase with increased arterial diameter provided a possible explanation for the decreased capacity to generate 20-HETE in the large arteries. The increase in CYP4A isoform expression and 20-HETE synthesis with decreasing diameter along the preglomerular arteries and the potent biological activity of 20-HETE underscore the significance of 20-HETE as a modulator of renal hemodynamics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060587     DOI: 10.1152/ajprenal.00265.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  17 in total

1.  Modulation by cytochrome P450-4A ω-hydroxylase enzymes of adrenergic vasoconstriction and response to reduced PO₂ in mesenteric resistance arteries of Dahl salt-sensitive rats.

Authors:  Gábor Raffai; Jingli Wang; Richard J Roman; Siddam Anjaiah; Brian Weinberg; John R Falck; Julian H Lombard
Journal:  Microcirculation       Date:  2010-10       Impact factor: 2.628

Review 2.  The role of 20-HETE in androgen-mediated hypertension.

Authors:  Cheng-Chia Wu; Michal Laniado Schwartzman
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-22       Impact factor: 3.072

3.  Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.

Authors:  Amanda Soler; Ian Hunter; Gregory Joseph; Rebecca Hutcheson; Brenda Hutcheson; Jenny Yang; Frank Fan Zhang; Sachindra Raj Joshi; Chastity Bradford; Katherine H Gotlinger; Rachana Maniyar; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Sachin A Gupte; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2018-02-08       Impact factor: 5.000

4.  Mechanisms of the vasorelaxing effects of CORM-3, a water-soluble carbon monoxide-releasing molecule: interactions with eNOS.

Authors:  Ali Alshehri; Marie-Pierre Bourguignon; Nicolas Clavreul; Cécile Badier-Commander; Willy Gosgnach; Serge Simonet; Christine Vayssettes-Courchay; Alex Cordi; Jean-Noël Fabiani; Tony J Verbeuren; Michel Félétou
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-01-08       Impact factor: 3.000

5.  Expression of CYP 4A ω-hydroxylase and formation of 20-hydroxyeicosatetreanoic acid (20-HETE) in cultured rat brain astrocytes.

Authors:  Debebe Gebremedhin; David X Zhang; Koryn A Carver; Nicole Rau; Kevin R Rarick; Richard J Roman; David R Harder
Journal:  Prostaglandins Other Lipid Mediat       Date:  2016-05-09       Impact factor: 3.072

6.  Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat.

Authors:  Fan Fan; Aron M Geurts; Sydney R Murphy; Mallikarjuna R Pabbidi; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-24       Impact factor: 3.619

Review 7.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

8.  20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling.

Authors:  Jennifer Cheng; Cheng-Chia Wu; Katherine H Gotlinger; Frank Zhang; John R Falck; Dubasi Narsimhaswamy; Michal Laniado Schwartzman
Journal:  J Pharmacol Exp Ther       Date:  2009-10-19       Impact factor: 4.030

9.  Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.

Authors:  Kazuyoshi Inoue; Komal Sodhi; Nitin Puri; Katherine H Gotlinger; Jiang Cao; Rita Rezzani; John R Falck; Nader G Abraham; Michal Laniado-Schwartzman
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-12

Review 10.  20-HETE in the regulation of vascular and cardiac function.

Authors:  Petra Rocic; Michal Laniado Schwartzman
Journal:  Pharmacol Ther       Date:  2018-07-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.